Indivior

INDV US Health Care Pharmaceuticals
S&P 600
$34.49
-0.06%
Delayed · cached 15 min

Fair value analysis

INDV
Indivior
Health CarePharmaceuticals
$34.49
Close used for this calculation
$34.32Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
43/100
Profitability23/25
Returns3/25
Balance Sheet9/25
Efficiency8/25
Growth12/25
Average
Quality radar
43Prof.23/25Ret.3/25Eff.8/25B.Sht9/25Growth12/25

Consensus fair value

$34.32
Near FV
▼ -0.5% against the close used
Model range $24.51 – $49.20
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$24.51Fair value$34.32Bull$49.20
FairClose
52-week traded range
52W low $22.5152W high $41.83

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

Indivior closed at $34.49, 0.5% above the consensus fair value of $34.32 drawn from 6 valuation models.

Financial DNA score 43/100 — Average. P/E of 21.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$32.55
-5.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
P/E Fair Value
$32.80
-4.9%
EPS × 20x (sector P/E)
EPS=1.64, Sector P/E=20x
Peter Lynch (PEG)
$49.20
+42.7%
EPS × Growth% (PEG = 1 is fair)
EPS=1.64, g=30%
EV/EBITDA
$37.27
+8.1%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=272M
Reverse DCF
$34.49
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7.8% | Historical: 40%
Margin of Safety
$24.51
-28.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=32.68, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.